| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | Consumer Defensive | UBS | Maintains | Neutral → Neutral | — | $1.1T | $25.48 | +0.0% | -0.7% | +0.3% | -0.3% | -1.3% | +0.4% |
| JNJ | Healthcare | Deutsche Bank | Maintains | Hold → Hold | — | $558.8B | $103.96 | +0.4% | -0.3% | -1.1% | -1.0% | -0.5% | +0.3% |
| INTC | Technology | UBS | Maintains | Buy → Buy | — | $538.0B | $33.15 | -0.3% | +0.7% | +0.5% | -0.3% | -1.0% | +1.8% |
| MA | Financial Services | CLSA | Maintains | Outperform → Outperform | — | $448.7B | $93.80 | +0.3% | -0.6% | -0.4% | -0.2% | -0.9% | +0.8% |
| ADI | Technology | UBS | Maintains | Neutral → Neutral | — | $197.7B | $63.45 | +1.2% | +4.3% | -1.0% | +2.5% | -0.4% | +2.2% |
| ADI | Technology | Stifel | Maintains | Buy → Buy | — | $197.7B | $63.45 | +1.2% | +4.3% | -1.0% | +2.5% | -0.4% | +2.2% |
| CRM | Technology | Barclays | Maintains | Overweight → Overweight | — | $171.5B | $71.48 | -0.3% | -1.8% | +3.9% | +2.9% | -1.9% | +0.5% |
| CRM | Technology | Nomura | Maintains | Buy → Buy | — | $171.5B | $71.48 | -0.3% | -1.8% | +3.9% | +2.9% | -1.9% | +0.5% |
| CRM | Technology | Deutsche Bank | Maintains | Buy → Buy | — | $171.5B | $71.48 | -0.3% | -1.8% | +3.9% | +2.9% | -1.9% | +0.5% |
| CRM | Technology | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $171.5B | $71.48 | -0.3% | -1.8% | +3.9% | +2.9% | -1.9% | +0.5% |
| CRM | Technology | FBR Capital | Maintains | Outperform → Outperform | — | $171.5B | $71.48 | -0.3% | -1.8% | +3.9% | +2.9% | -1.9% | +0.5% |
| CRM | Technology | RBC Capital | Maintains | Outperform → Outperform | — | $171.5B | $71.48 | -0.3% | -1.8% | +3.9% | +2.9% | -1.9% | +0.5% |
| CRM | Technology | JP Morgan | Maintains | Overweight → Overweight | — | $171.5B | $71.48 | -0.3% | -1.8% | +3.9% | +2.9% | -1.9% | +0.5% |
| PANW | Technology | Evercore ISI | Maintains | Hold → Hold | — | $170.3B | $26.39 | -0.5% | +0.1% | +1.0% | +1.7% | +0.6% | -2.0% |
| TMO | Healthcare | Jefferies | Maintains | Buy → Buy | — | $168.8B | $130.55 | +0.0% | +1.1% | +0.6% | -0.5% | -1.8% | +0.9% |
| TMO | Healthcare | Barclays | Maintains | Overweight → Overweight | — | $168.8B | $130.55 | +0.0% | +1.1% | +0.6% | -0.5% | -1.8% | +0.9% |
| UBS | Financial Services | BofA SecuritiesA | Upgrade | Neutral → Buy | — | $150.6B | $21.13 | +3.2% | +3.9% | -0.3% | -1.2% | -1.3% | +2.1% |
| INTU | Technology | Raymond James | Maintains | Strong Buy → Strong Buy | — | $113.1B | $103.27 | +0.4% | +0.1% | +0.8% | +2.5% | -2.0% | +0.5% |
| BNS | Financial Services | BofA Securities | Downgrade | Neutral → Underperform | — | $98.3B | $53.37 | -0.2% | -1.0% | +0.7% | -1.3% | -1.6% | +0.2% |
| APO | Financial Services | Morgan StanleyB | Upgrade | Underweight → Equal Weight | — | $80.4B | $21.56 | +2.7% | +1.1% | -0.6% | +0.3% | +0.2% | +0.8% |